ALBANY, N.Y.--(BUSINESS WIRE)-- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced that Scott Solano, Senior Vice President and Chief Technology Officer, has resigned his position effective October 14, 2011, to pursue other interests. Mr. Solano joined AngioDynamics in September 2010.

"We are disappointed that Scott has decided to leave AngioDynamics," said Joseph DeVivo, President & CEO. "During the past year, Scott contributed significantly to our technology direction and product pipeline. With Scott's full cooperation, we are implementing an orderly transition of his responsibilities."

"My decision to leave AngioDynamics is a personal one," said Mr. Solano. "I believe the Company is well positioned for future growth and wish all of the employees great success in the years ahead."

About AngioDynamics

AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at www.AngioDynamics.com.

AngioDynamics, Inc.
Company Contact:
D. Joseph Gersuk, CFO, 800-772-6446 ext. 1608
jgersuk@AngioDynamics.com
or
EVC Group, Inc.
Investor Relations Contacts:
Greg Gin, 646-445-4801
ggin@evcgroup.com
Doug Sherk, 415-652-9100
dsherk@evcgroup.com
or
Media Contact:
Chris Gale, 646-201-5431
cgale@evcgroup.com

Source: AngioDynamics, Inc.

News Provided by Acquire Media